A detailed history of Panagora Asset Management Inc transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Panagora Asset Management Inc holds 136,350 shares of ALDX stock, worth $653,116. This represents 0.0% of its overall portfolio holdings.

Number of Shares
136,350
Previous 60,298 126.13%
Holding current value
$653,116
Previous $199,000 268.84%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.19 - $6.32 $242,605 - $480,648
76,052 Added 126.13%
136,350 $734,000
Q2 2024

Jul 29, 2024

BUY
$3.25 - $4.72 $195,968 - $284,606
60,298 New
60,298 $199,000
Q3 2021

Nov 10, 2021

SELL
$7.94 - $11.31 $3,652 - $5,202
-460 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$10.44 - $14.85 $1,075 - $1,529
-103 Reduced 18.29%
460 $5,000
Q4 2020

Feb 10, 2021

BUY
$6.31 - $8.13 $3,552 - $4,577
563 New
563 $4,000
Q2 2020

Aug 12, 2020

SELL
$1.97 - $5.05 $78,075 - $200,141
-39,632 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$1.62 - $6.4 $32,698 - $129,177
20,184 Added 103.78%
39,632 $98,000
Q4 2019

Feb 12, 2020

BUY
$4.73 - $7.98 $91,989 - $155,195
19,448 New
19,448 $113,000

Others Institutions Holding ALDX

About Aldeyra Therapeutics, Inc.


  • Ticker ALDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,323,100
  • Market Cap $279M
  • Description
  • Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...
More about ALDX
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.